NCT00543192

Brief Summary

The purpose of this study is estimate how sexual function in endometrial cancer survivors varies with severity of disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
73

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2007

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2007

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

October 10, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 12, 2007

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2009

Completed
Last Updated

November 19, 2019

Status Verified

September 1, 2009

Enrollment Period

1.7 years

First QC Date

October 10, 2007

Last Update Submit

November 15, 2019

Conditions

Endometrial CancerSexual Function

Keywords

Endometrial CancerSexual Function

Outcome Measures

Primary Outcomes (1)

  • Female Sexual Function Index (FSFI).

    at time of enrollment

Eligibility Criteria

Age19 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

University of Wisconsin Gynecologic Oncology and Radiation Oncology Clinics

You may qualify if:

  • History of Stage I-IIIA endometrial adenocarcinoma of any grade
  • years out from primary surgical treatment
  • Adjuvant therapy may only have consisted of radiation or hormonal therapy
  • No evidence of disease

You may not qualify if:

  • Previous treatment for other malignancies
  • Did not undergo surgery for primary treatment of endometrial cancer
  • Inability to read, write and speak fluent English
  • Major cognitive impairment affecting ability to provide consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Wisconsin School of Medicine and Public Health

Madison, Wisconsin, 53792, United States

Location

Related Publications (1)

  • Onujiogu N, Johnson T, Seo S, Mijal K, Rash J, Seaborne L, Rose S, Kushner DM. Survivors of endometrial cancer: who is at risk for sexual dysfunction? Gynecol Oncol. 2011 Nov;123(2):356-9. doi: 10.1016/j.ygyno.2011.07.035.

    PMID: 21855974RESULT

Related Links

MeSH Terms

Conditions

Endometrial Neoplasms

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • David M Kushner, MD

    University of Wisconsin, Madison

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 10, 2007

First Posted

October 12, 2007

Study Start

October 1, 2007

Primary Completion

June 1, 2009

Study Completion

June 1, 2009

Last Updated

November 19, 2019

Record last verified: 2009-09

Locations

US(1)